Mira Kyivska

Chainlink faces resistance at $9.9 as downtrend persists: weekly outlook

Chainlink faces resistance at $9.9 as downtrend persists: weekly outlook
Chainlink falls 11.95% over the week

Chainlink (LINK) is trading around $8.80 after falling more than 10% over the past week, as institutional developments draw attention. A new partnership between Chainlink and UBS is setting the stage for traditional finance integration, which could reshape the outlook for the coming days.

LINK price prediction
24H -7.09%
$8.13
48H -9.83%
$7.89
7D -10.74%
$7.81
1M -31.31%
$6.01
3M -51.31%
$4.26
6M -60.11%
$3.49
12M -10.51%
$7.83
Current price: $8.75 -0.43 4.73%
Real-time Data 12:32
Daily range 8.7 Arrow from to Icon 9.08
Weekly range 8.57 Arrow from to Icon 9.90
Loading...

Highlights

  • Chainlink has fallen 11.95% over the past 7 days to $8.82, trading near the lower boundary of its recent range.
  • Technical indicators show a strong downtrend with negative momentum, trades below key moving averages, and the price is oversold.
  • Forecast range for the next 7 days is $8.11 to $9.52, with immediate support at $8.57 and strong resistance at $9.9.

UBS partnership advances tokenized notes as on-chain adoption accelerates

Chainlink and UBS have joined forces to deliver a blockchain-based solution for issuing and managing tokenized structured notes on Ethereum, targeting the global structured products market worth over $2 trillion according to PR Newswire (source: PR Newswire). The project utilizes Chainlink's Runtime Environment to enable smoother integration with UBS's existing banking systems, streamlining critical lifecycle processes and settlement. CryptoBriefing reported that UBS has already piloted the system, with further plans to add digital-money settlement integration.

Chainlink asset chart
Chainlink price dynamics. Source: TradingView.

Firm downtrend persists as technical signals flag potential rebound

On the daily chart, Chainlink is in a firm downtrend, highlighted by a sustained move lower with a firm trend and seven-day volatility of 15.52%. MACD and ADX both align on sell signals, reinforcing negative momentum, while CCI is reading oversold at -106.32 to suggest selling exhaustion and potential for a technical rebound. Immediate support is at $8.57 with resistance at $9.9, while the Ichimoku Kijun at $10.3 adds an additional resistance area that could cap any bounce.

Further downside expected as resistance limits any recovery this week

For the next 7 days, the expected range is $8.11 to $9.52. There is a very high probability (more than 80%) of a further decline and a very low probability of an increase. Base case is continued trading in the defined range, with any rally toward $9.9 likely meeting strong resistance. A close above resistance would challenge the negative trend, while a break below $8.57 support could accelerate selling toward $8.11.

Sholanke Dele, market strategist, sees Chainlink trading under pressure this week after a more than 10% decline and limited signs of technical relief. Despite the significant partnership with UBS to bring tokenized structured notes to Ethereum, sentiment remains subdued as technical signals confirm selling momentum. Both MACD and ADX suggest continued negative momentum, while oversold CCI hints at possible exhaustion with only minor rebound scope. Resistance is firm at $9.9 and $10.3, and any break below immediate support at $8.57 could fuel further selling toward $8.11. "Institutional news is promising, but as long as Chainlink trades below resistance, I remain defensive and expect downside risk to dominate the week ahead."

Earlier, analysts noted that Chainlink was consolidating above short-term averages, with institutional partnerships presenting a potential inflection point for the asset’s direction. The current breakdown below support, despite the high-profile collaboration with UBS, places increased focus on the risk of further downside, making $8.57 a critical level to monitor for signs of accelerated selling.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.